Mitigating Risk In Process Automation

In this segment of Cell & Gene Live, Driving Down COGS: Automation’s Role in Cell Therapy Manufacturing featuring Craig Beasley, Chief Technical Officer at BlueRock Therapeutics and Narinder Singh, Chief Technical Officer at Arcellx cover the various ways in which automation helps to reduce risk and why closing systems and reducing the number of manual manipulations is so critical.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene

Thermo Fisher Scientific Bioproduction